Decentralized clinical trials (DCTs) and hybrid trials are rapidly shaping the future of clinical research. New developments in health apps, telemedicine and wearable devices are the main drivers of this shift, offering new ways to collect data and improve patient engagement. But for DCTs to reach their full potential, technology alone isn’t enough—we also need comprehensive and personal support for both patients and clinical staff.

A recent article at clinicaltrialsarena.com highlights data from GlobalData’s Clinical Trials Database, confirming that decentralized clinical trials are experiencing significant growth. More than 1,500 decentralized clinical trials started in 2024, and an even higher number of DCTs are expected to launch in 2025. It stands clear that DCTs are rapidly breaking down geographical and demographical barriers that historically have caused underrepresentation of certain patient groups in traditional trials.

The value of personal support

However, technology alone isn’t sufficient. Most patients still require personalized support to navigate digital devices or to feel safe in their new treatment regime. On the clinical side, the site staff need adequate training to manage decentralized workflows effectively. This cannot – and should not – be all digitalized and automated.
That’s why we believe in a holistic approach, combining the best of two worlds: cutting-edge technology and personalized support systems. Through our global network of dedicated mobile nurses, we make sure that no one is left behind. This creates a future for clinical trials that results in better data for the research companies, but also delivers an improved experience for everyone involved—patients, researchers, and healthcare providers alike.

Please reach out to learn more about our global offer.